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Tumors progress in immunocompetent hosts despite the
ability of the adaptive immune system to recognize can-
cer cells. Ion gradients regulate T cell function but their
role in intratumoral immune responses is unexplored.
We found that the concentration of K+ was strikingly
elevated within tumors while the concentration of the
divalent cations Ca2+ and Mg2+ was similar to serum
levels. High K+ levels significantly blunted cytokine pro-
duction and suppression TCR stimulation induced gene
transcription in CD8+ and CD4+ effector T cells. More-
over, polarization of CD8+ and CD4+ T cells in high K+
suppressed effector differentiation and promoted the
formation of CD4+ Foxp3+ Treg cells. Surprisingly, this
was not due to an attenuation of TCR induced Ca2+
flux, but rather to reduced activation of the serine/
threonine Akt-mTOR pathway and could be partially
reversed by overexpression of constitutively active Akt1.
This coincided with the finding that okadaic acid, an inhi-
bitor of the serine/threonine phosphatase PP2A, rendered
effector cells resistant to the inhibitory effects of high K+
and restored cytokine function within tumors. Addition-
ally, expression of a peptide inhibitor targeting the PP2A
complex provided resistance to the inhibitory effect of ele-
vated K+. These findings identify a novel mechanism of
ionic regulation of TCR induced signals and immunosup-
pression within tumors whereby locally high extracellular
concentrations of normally intracellular ions suppress
immune function to promote tumor growth.
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